Theratechnologies to be acquired by CB Biotechnology for $3.01 per share

From GlobeNewswire: 2025-07-02 22:11:00

Theratechnologies Inc. announced a binding arrangement agreement with CB Biotechnology, LLC for US$3.01 per share in cash plus one contingent value right for additional payments, totaling US$254 million. The transaction with Future Pak represents a 216% premium to Nasdaq’s closing price before the announcement. The deal is part of a sale process after soliciting interest from potential buyers. The Board unanimously recommends shareholders approve the transaction, which is expected to close by November 30, 2025. Future Pak plans to fund the acquisition through a combination of debt financing and cash on hand.



Read more at GlobeNewswire: Theratechnologies enters into Definitive Agreement to be